The News
TRID, Trident Microsystems, NEWN, New Energy, Summary, Profile
Stocks to Watch!
TRID, Trident Micro, NEWN, New Energy
TRID - Trident Microsystems provides semiconductor solutions for the digital home entertainment market. It designs, develops, and markets integrated circuits and related software for processing, displaying, transmitting audio and images in home consumer electronics applications, such as digital TVs, PC and set-top boxes.
The company's main customers are (OEM) Original Equipment Manufacturers. Trident has a large customer base. Very Attractive, Bouncing back from 52WK Lows, keep an eye!
NEWN - New Energy Systems, manufactures and distributes lithium battery shells and related products primarily in China. It develops, customizes, and produces steel and aluminum battery shells and caps. The company principally serves large lithium battery manufacturers. Bouncing back from 52WK Lows, Very Attractive.
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.
ENDURA is The 'KODAK' moment for Eastman KODAK, EK
ENDURA could be The 'KODAK' Moment for EK
Eastman Kodak – EK - provides imaging technology products and services to the photographic and graphic communications markets worldwide. It has three divisions, Consumer Digital Imaging Group (CDG); Film and Entertainment Group (FPEG); and Graphic Communications Group (GCG).
We strongly believe ENDURA could be the 'KODAK' moment investors have been looking for!
KODAK PROFESSIONAL ENDURA Premier Paper
KODAK PROFESSIONAL ENDURA Premier Paper provides unique benefits by maintaining natural-looking skin tones, from highlights to shadows, while expanding color gamut, enabled by a technological breakthrough, the latest advancement in coupler technology. This innovation also provides a lighter/brighter D-Min for cleaner-looking whites, and at the same time a higher D-Max capability for bold rich blacks, better contrast and exceptional performance in typical home display.
More than 75 million people worldwide manage, share and create photo gifts online at KODAK Gallery-- at www.kodakgallery.com. We see a huge potential and this could revive the company and the stock. Very, VERY, Attractive, Huge Patent portfolio, Medium-Long Term Play.
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® Always Read the full Disclosure/Disclaimer. Thanks.
ALZM, Allezoe Medical, Summary, Profile
Stock to Watch!
Allezoe Medial, ALZM
Allezoe Medical has just launched a new subsidiary - SureScreen Medical - SureScreen will be responsible for taking HPV diagnostic technology through the appropriate trials and federal clearances.
HPV is linked to a number of cancers in both men and women, and it is the most common sexually transmitted infection and most people who become infected are completely unaware of it. Approximately 20 million Americans are infected with HPV — Experts believe that more than 5 million new infections occur each year.
Allezoe – ALZM – recently acquired a company that invented a breakthrough medical technology for the diagnosis and treatment of Human Papillomavirus (HPV), Bovine Papillomavirus (BPV), and potentially cervical cancer
In addition Allezoe also has a subsidiary - Organ Transport Systems (OTS), a biomedical company developing and commercializing portable hypo-thermic, oxygenated preservation and transport technology for human organs.
The company is aggressively moving toward regulatory approval and commercialization of HPV treatment. It could be very lucrative because of its potential market size and relatively hassle free reimbursement from insurance companies.
The stock hit the bottom under heavy selling pressure and starting to bounce back. The recent acquisition and over sold conditions make it very attractive, short to medium term, very speculative and expect above average volatility.
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.
PPHM, Peregrine Pharmaceuticals, Profile, Summary
Stock to Watch!
PPHM – Peregrine Pharmaceuticals
PPHM - Peregrine Pharmaceuticals is a biopharmaceutical company, engages in the research and development of monoclonal antibodies for the treatment of cancer and viral infections. Its products under development include bavituximab, which is in Phase II trials for the treatment of lung cancer and pancreatic cancer. The company is also developing ribavirin, which is in Phase II clinical trial for the treatment of patients with genotype-1 hepatitis C virus infections, liver cancer, prostate cancer and breast cancer.
Peregrine Pharma – PPHM - also provides contract manufacturing of antibodies, recombinant proteins, and enzymes; cell culture development; process development; and testing for biopharmaceutical and biotechnology companies. The company has licensing agreements with the University of Texas Southwestern Medical Center, Merck and SuperGen.
Great potential, Undervalued, Bouncing back from 52WK LOWS!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.
OTCKing
Feed Entries
